CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
33.14
-0.89 (-2.62%)
At close: Apr 1, 2025, 4:00 PM
33.48
+0.34 (1.03%)
After-hours: Apr 1, 2025, 7:57 PM EDT
CRISPR Therapeutics AG (CRSP) Operating Expense Breakdown
History
| Date | Research and Development | General and Administrative | Collaboration |
|---|---|---|---|
| Dec 31, 2024 | 320.65M | 72.98M | - |
| Sep 30, 2024 | 333.64M | 71.33M | 130.25M |
| Jun 30, 2024 | 342.18M | 72.20M | 142.52M |
| Mar 31, 2024 | 363.57M | 71.76M | 135.02M |
| Dec 31, 2023 | 387.33M | 76.16M | 130.25M |
| Sep 30, 2023 | 395.74M | 80.85M | 117.07M |
| Jun 30, 2023 | 421.67M | 89.56M | 132.51M |
| Mar 31, 2023 | 443.34M | 96.80M | 121.80M |
| Dec 31, 2022 | 461.65M | 102.46M | 110.25M |
| Sep 30, 2022 | 461.19M | 104.97M | 135.25M |
| Jun 30, 2022 | 428.06M | 101.68M | 118.86M |
| Mar 31, 2022 | 387.17M | 104.21M | 111.88M |
| Dec 31, 2021 | 339.55M | 100.71M | 101.18M |
| Sep 30, 2021 | 318.82M | 102.80M | 69.35M |
| Jun 30, 2021 | 306.33M | 100.63M | 46.89M |
| Mar 31, 2021 | 283.37M | 93.18M | 19.95M |
| Dec 31, 2020 | 266.95M | 88.21M | - |
| Sep 30, 2020 | 233.34M | 79.71M | - |
| Jun 30, 2020 | 219.58M | 73.69M | - |
| Mar 31, 2020 | 199.73M | 68.11M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.